» Authors » Scott Cameron

Scott Cameron

Explore the profile of Scott Cameron including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 2716
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Minami H, Doi T, Toyoda M, Imamura Y, Kiyota N, Mitsuma A, et al.
Cancer Sci . 2020 Oct; 112(2):725-733. PMID: 33031626
Spartalizumab is a humanized IgG4/κ mAb directed against human programmed cell death-1 (PD-1). In this phase I study, we investigated safety, pharmacokinetics, preliminary antitumor activity, and toxicity of spartalizumab in...
12.
Lachant D, Bach C, Wilson B, Chengazi V, Goldman B, Lachant N, et al.
Pulm Circ . 2020 Oct; 10(3):2045894020952019. PMID: 33014336
Long-term outcomes after acute pulmonary embolism vary from complete resolution to chronic thromboembolic pulmonary hypertension (CTEPH). Guidelines after acute pulmonary embolism are generally limited to anticoagulation duration. We assessed patients...
13.
Barnes G, Muzikansky A, Cameron S, Giri J, Heresi G, Jaber W, et al.
JAMA Netw Open . 2020 Aug; 3(8):e2010779. PMID: 32845326
Importance: The risk of death from acute pulmonary embolism can range as high as 15%, depending on patient factors at initial presentation. Acute treatment decisions are largely based on an...
14.
Koza A, Jerdan R, Cameron S, Spiers A
Microbiology (Reading) . 2020 Jun; 166(8):707-716. PMID: 32520698
Model bacterial biofilm systems suggest that bacteria produce one type of biofilm, which is then modified by environmental and physiological factors, although the diversification of developing populations might result in...
15.
Ayers B, Wood K, Cameron S, Marinescu M, Bjelic M, Barrus B, et al.
Ann Thorac Surg . 2020 May; 110(6):e493-e495. PMID: 32473129
We present the successful use of surgical embolectomy (SE) without systemic anticoagulation to treat a complicated case of pulmonary embolism. The patient presented with an embolic cerebrovascular accident and subsequently...
16.
Liu J, Hansen A, Cameron S, Bi P
Commun Dis Intell (2018) . 2020 May; 44. PMID: 32418511
Introduction: Ross River virus (RRV) disease is Australia's most common arthropod-borne disease which has an important impact on population health and productivity. The aim of this study was to identify...
17.
Capdevila J, Wirth L, Ernst T, Aix S, Lin C, Ramlau R, et al.
J Clin Oncol . 2020 May; 38(23):2620-2627. PMID: 32364844
Purpose: Anaplastic thyroid carcinoma is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options for patients with -wild type disease. As part of a phase...
18.
Estes M, Prendergast K, MacMahon J, Cameron S, Aboubechara J, Farrelly K, et al.
Brain Behav Immun . 2020 Apr; 88:619-630. PMID: 32335198
Despite the potential of rodent models of maternal immune activation (MIA) to identify new biomarkers and therapeutic interventions for a range of psychiatric disorders, current approaches using these models ignore...
19.
Naing A, Gainor J, Gelderblom H, Forde P, Butler M, Lin C, et al.
J Immunother Cancer . 2020 Mar; 8(1). PMID: 32179633
Background: Spartalizumab is a humanized IgG4κ monoclonal antibody that binds programmed death-1 (PD-1) and blocks its interaction with PD-L1 and PD-L2. This phase 1/2 study was designed to assess the...
20.
Salmon C, Pribiag H, Gizowski C, Farmer W, Cameron S, Jones E, et al.
Front Cell Neurosci . 2020 Mar; 14:36. PMID: 32161521
γ-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the mature brain but has the paradoxical property of depolarizing neurons during early development. Depolarization provided by GABA transmission during this...